Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure
Sponsor: M.D. Anderson Cancer Center • ClinicalTrials.gov ID: NCT02464696
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
This randomized clinical trial studies how well non-invasive ventilation works in reducing the need for intubation, or placement of a tube in the windpipe, in patients with cancer and respiratory failure. Respiratory failure is a condition in which not enough oxygen passes from the lungs to the blood, and is a common cause of admission to the emergency room in patients with hematological and solid tumor patients. Non-invasive positive pressure ventilation (NIPPV) is a method of delivering oxygen using a mask. It is not yet known whether NIPPV is better at improving the amount of oxygen in the blood, reducing shortness of breath, and the need for intubation than standard high flow oxygen (a tube with 2 prongs placed in the nostrils) in patients with cancer and respiratory failure.
Interventions
-
Methylprednisolone
(Drug)
IPS cohort only
-
Oxygen Therapy
(Procedure)
Receive high flow oxygen therapy
-
Positive Air Pressure Device
(Device)
Undergo NIPPV
Eligibility criteria
Conditions
Locations
- M D Anderson Cancer Center — Houston, Texas, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record